Biocon, BahiaFarma, Bionovis Ink MoU to Co-Develop Breast Cancer Therapy
The pact was signed for the development of Pertuzumab, indicated for HER-2 metastatic breast cancer.
Health
STAT+: FDA unveils rules for bespoke gene therapies, predicting flood of rare disease applicationsÂ
The FDA expects a flood of applications for a new "plausible mechanism pathway" for approval of bespoke gene-editing treatments.
Ticagrelor Not Noninferior to Prasugrel After PCI in Diabetes: JAMA
In a recent study, ticagrelor was found to be noninferior to prasugrel for a composite of ischemic events including death, myocardial infarction, stroke, and major bleeding after a year in…
Nitazoxanide-Based Therapy Shows Higher H. pylori Eradication Rates, Suggests Research
Pakistan: A study published in the Journal of Clinical Gastroenterology has reported that nitazoxanide-based regimens achieve higher Helicobacter pylori eradication rates compared with standard triple therapy.Standard treatment consists of a…
UB researchers develop new inhalable treatment for TB: Study
Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the…
Longer Door-In–Door-Out Times Linked to Worse Outcomes in Acute Ischemic Stroke: Study
A new study published in the journal of The Lancet Neurology found that patients with Door-In–Door-Out (DIDO) times exceeding 90 minutes had lower odds of receiving endovascular therapy and higher…
Terlipressin Can Serve as an Effective Bridge to Transplant in Pediatric HRS-AKI, Suggests Study
UK: Children with chronic liver disease are particularly vulnerable to acute kidney injury (AKI), including hepatorenal syndrome–acute kidney injury (HRS-AKI), a severe complication associated with significant morbidity and mortality. A…
Low-Dose Aspirin Increases Cancer Mortality Without Reducing Cancer Incidence in Older Adults: JAMA
Long-term follow-up of the ASPREE randomized trial and its observational extension showed that older adults taking low-dose aspirin had a significantly higher risk of cancer-related mortality compared with placebo, while…
STAT+: Novo’s next-gen obesity drug stumbles in Lilly comparison study
And other biotech news brought to you by The Readout
STAT+: Pharmalittle: We’re reading about pharma lobbying, a disappointing Novo clinical trial, and much more
Pharmaceutical companies are boosting their spending on lobbying firms with connections to the White House